StockWatch
·

Gulf Oil Lubricants India Ltd Q2 FY27 Results

GULFOILLUBQ2 FY27 Results
Filing
Result:Good· Market: Flat#Margin squeeze

Outlook: Optimistic · Guidance: Maintained

MetricValue (₹ Cr)Q1 FY27Q2 FY26
Revenue1.4K6.1%45.7%
Total Income1.4K6.0%44.7%
Expenditure1.3K7.8%45.8%
PBT153.986.5%36.1%
Net Profit114.525.2%36.4%
OPM11.61%0.88pp0.53pp
NPM7.98%0.94pp0.48pp
EPS23.306.3%34.3%
View full financials

Revenue (+45.7% YoY) and adjusted PAT (+36.4% YoY) both grew strongly for this manufacturing/lubricants business, but core profitability quality is capped by OPM slipping to 11.6% (below the 12-14% guided band) and NPM compressing YoY/QoQ on rising raw-material costs, with profit growth trailing revenue growth.

GULF OIL LUBRICANTS INDIA LTD · QQ2 FY-2027 · THE CALL

Strong momentum, margins holding—but sequential PAT dipped on seasonality

The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.

05 Nov 2026 · 6 min read
Verdict

Hold

confidence 7/10

Credibility

Grade B

Hit volume targets (16% core vs 2x–3x market = 6–12% expected); EBITDA +37% YoY; margins held at 11.6% in inflation. Sequential PAT decline flags cost/WC pressure not yet fully passed through.

Short-term outlook

Optimistic

next 1–2 quarters

Long-term outlook

Optimistic

multi-year

Strong YoY momentum (46% revenue, 16% core volume growth vs 3–4% market) validates 2–3x guidance. However, sequential softness (PAT −5.2%, OPM 11.6% below band) and rising working capital offset enthusiasm. Margin expansion to 14–16% remains aspirational; near-term execution on capacity ramp and cost absorption will determine credibility.

₹1408.7 Cr

Revenue · +45.7% YoY

₹114.5 Cr

Reported PAT · +36.4% YoY

Compressing

Margins · vs guidance: Corroborated

Did the claims hold up?

Management's claims vs. the numbers

Core lubes 16% growth, 3–4x industry outperformance

MET

Q2 revenue +45.7% YoY, core volume +16% QoQ vs 3–4% industry baseline = 4–5x outperformance

EBITDA 37% growth Y-o-Y, margins in 12–14% band

MET

OPM 11.6% in Q2 (just below 12% band); YoY PAT +36.4% corroborates EBITDA claim; NPM 8.0% (below guidance envelope, indicating interest/depreciation burden)

Q2 very good quarter, stronger than Q1 supply-driven quarter

OVERSTATED

Q2 revenue +6.1% QoQ but PAT −5.2% QoQ, confirming monsoon seasonality; YoY strong at +45.7% revenue but comparison is to weak Q2 FY26

Tirex 78% growth, ₹33 Cr run rate in Q2

MET

₹33 Cr in Q2 (78% growth vs ₹18 Cr Q2 FY26 base); tracking to ₹300–400 Cr in 3–4 years requires 10–12x from current, very early stage

Earnings quality

What changed since the last call

Deltas vs. the prior call

Capex quantum increased

Upgrade

₹55 Cr initial → ₹60–62 Cr post-Board sanction (₹7 Cr additional); timeline to full capacity by Q4 FY27 (1–2 month risk to Q1 FY28 spillover).

Margin outlook kept to band

Neutral

Reaffirmed 12–14% EBITDA maintenance with 14–16% upside via premiumization; delivered 11.6% OPM this quarter, no expansion yet vs Q1 parity.

H2 volume guidance maintained

Neutral

2x–3x market growth reaffirmed for H2 and forward; agri seasonality expected to lift H2 demand; no upgrade despite strong Q2 execution.

The Q&A

Analysts pressed on margin sustainability amid cost inflation and working capital drag; management held firm on per-litre defence, pricing power by segment, and eventual 14–16% band via mix shift. Some scepticism on AdBlue double-digit target vs monsoon/seasonality headwind; management confident on structural market growth.

The exchanges that mattered

Working capital & inventory — Pankaj, Avis Capital

Partial

Prices up, so both inventory and receivable values up. Gross days still in 95–105 band, historically normal. Moderation expected if prices don't escalate further.

Fire incident impact — Pankaj, Avis Capital

Answered

Stocks covered by insurance; 4–5 days equivalent production lost; other warehouses operational; no supply disruption expected. Recoverable in alternate plants.

H2 sales expectations — Mukund Agarwal, BMC Advisors

Partial

Q1 17% growth, Q2 16% growth; H2 expected good due to festive season and normal weather. 3–4% industry growth baseline; targeting 2x–3x, close to double-digit growth in volume.

Margin trajectory — Mukund Agarwal, BMC Advisors

Partial

Medium-to-long term trajectory. Currently 11.8% after inflationary pressures. If prices stabilise and mix shifts, will target 14–16%. No fixed timeline given.

Dividend payout — Mukund Agarwal, BMC Advisors

Answered

Increasing dividend payouts over time. Last year ~65–70%. Using cash for M&A opportunities in core and adjacencies; excess cash returned to shareholders.

Tirex revenue & growth — Dhaval Popat, Choice International

Answered

₹33 Cr in Q2 (78% growth). 70% EV cars, buses selling more. 3,000 charger capacity by end FY27. Expanding OEM and CPO portfolio.

B2C & OEM market share — Dhaval Popat, Choice International

Answered

B2C 50% of volumes. Targeting 2x market growth via OEM franchisee workshops (~7,000 active) and distribution expansion (90,000 → ~100,000 outlets, +10–15% per quarter).

Price increases & cost pass-through — Arya Patel, Emkay Global

Partial

Watching crude movements closely. Price moves monthly; have passed on increases to maintain per-litre margins. Additive and other costs also up; monitoring for recalibration if crude sustains.

Crude price impact & margin defence — Arya Patel, Emkay Global

Partial

Crude at $100–$115; timing lag for base oil pass-through. Have taken calibrated actions; if crude stays elevated, may need price increases segment-wise. Sufficient cover so far for current impact.

AdBlue volume outlook — Hardik Solanki, ICICI

Answered

Q2 down (monsoon). Going forward, double-digit 10–15% growth as BS-VI population rises. Current trajectory calibrated to market, not exponential.

Pricing gap vs Castrol — Hardik Solanki, ICICI

Dodged

Top 2–3 in categories; pricing varies by segment and product strength. OMC data not available; market share gains 7–8% total, growing 2x–3x market.

Freight and input cost escalation — Sivasankaran, Antique Limited

Answered

Freight up due to Hormuz strait delays. All on CIF basis, built into base oil cost indices. No incremental impact separately; all pass-through mechanisms in place.

Inventory and P&L adjustments — Raghav Agarwal, BMC Advisors

Answered

Prices up continuously; extra buying for supply security; combined impact of tactical buying + price revaluation. Expects moderation once prices normalise.

EBITDA to CFO conversion — Devang Patel, Sameeksha Capital

Partial

No particular seasonality. H1 crimping due to cost inflation, prices up, extra working capital deployed. H2 from now, if prices stable, incremental cash to balance sheet, not WC.

Cash deployment plan — Dhaval Popat, Choice International

Answered

War chest for M&A in lubricants and adjacencies (mobility, EV value chain). Increased dividend payouts to 65–70%. Open to M&A if industrial segment or EV-adjacent opportunities arise.

Capex status & timeline — Prashant, Individual Investor

Answered

Chennai on track, capacity increase by Q4 FY27. Silvassa progressing, possible 1–2 month delay to Q1 FY28 spillover. Running third shifts at both plants as interim.

Capex quantum and sanction — Prashant, Individual Investor

Answered

₹55 Cr initially; ₹7 Cr additional recently sanctioned. Total ₹60–62 Cr for expansion.

B2C vs B2B channel split — Ankit, Individual Investor

Answered

B2C 50%, B2B 50% (includes industrial). Personal mobility ~21% of volume; PCMO <5% market share; targeting 3–4% via Custom Car Stop and premium synthetic focus.

Export contribution — Ankit, Individual Investor

Answered

Exports 9–10% of lubes business; grew in H1 due to global supply-demand tightness; will remain ~9–10% baseline.

Synthetic product roadmap — Ankit, Individual Investor

Answered

Aiming 10% synthetic contribution in 3–4 years from current lower base; motorcycle products like 'Syntrac' already in pipeline; will scale over next 3–4 years, including car range.

Other expenses reduction — Mohit, Indium Investments

Answered

Freight, OEM-linked royalties, AdBlue volumes (lower), and mega campaign spend differences. A&P spent heavily on 'Pride' campaign in Q1. Other expenses vary by segment and sales mix.

Margin profile & B2C B2B strategy — Probal Sen, ICICI

Partial

OEM franchisee workshop profitable; bazaar brand 'number two' premium positioning. Strategy is volume + margin together, not trade-off. B2C targets 2x market growth, B2B 3x. Margins stay 55–45 B2C–B2B split, not diluting. Eventually trajectory 14–16% via mix + operating leverage.

OMC competitive positioning — Probal Sen, ICICI

Answered

OMCs form 30–35% of market; expanding base oil capacity, less imports. Will augment making more product in-house. No change in fundamental market dynamics; continued focus on supply security and margin.

Guidance

Forward guidance and management's confidence

FY27: 2–3x industry growth (vs 3–4% market baseline)

Medium

Reaffirmed at Q2 call. H1 delivered 17% volume growth H1 YoY, roughly 4–5x market (beats guidance). H2 expected similar trajectory; dependent on agri seasonality and macro stability.

EBITDA 12–14% band, trajectory to 14–16% via premiumization

Medium

Q2 delivered 11.6% OPM (at lower end of guidance). Management attributes to input cost inflation. Per-litre margin stable; eventual margin expansion dependent on mix shift and cost stabilisation—no clear timeline.

₹60–62 Cr expansion capex; capacity online by Q4 FY27

Medium

Chennai on track, Silvassa may slip 1–2 months to Q1 FY28. 70% capacity increase phased in; third-shift operations interim. Total program raises capacity for ~2x CAGR target.

Risks the call surfaced

Ranked by how much they should concern a holder

Cost inflation & margin pressure

Medium

Crude, additives, freight all up; customer acceptance of price hikes variable by segment. Q2 margin 11.6% below 12–14% guidance; risk of further compression if cost inflation outpaces pricing.

Working capital cycle management

Medium

Inventory days in 95–105 band (normal historically) but absolute values up ₹109 Cr (Q1) + ₹88 Cr (Q2) due to price-driven revaluation and tactical buying. Risk: if prices don't stabilise, WC remains elevated and cash flow weakens.

Capacity expansion execution risk

Medium

Chennai 70% capacity increase target by Q4 FY27 on track; Silvassa expansion flagged for 1–2 month spillover to Q1 FY28. Delay could defer margin leverage benefits and force third-shift operations longer (cost burden).

Seasonality & demand volatility

Medium

Q2 (monsoon) PAT down 5.2% QoQ despite 45.7% YoY revenue growth; monsoon + agri season create predictable but material demand dips. Risk: H2 recovery not assured if macro deteriorates.

Competitive intensity from OMCs

Low

OMCs (Indian Oil, BPCL, Hindustan Petroleum) form 30–35% of lubrican market; expanding in-house base oil capacity to reduce imports and boost profitability. Risk: OMCs could shift from wholesale purchasing to own manufacturing, squeezing Gulf's market access.

Management

Score 7/10. Clear on operational metrics and segment breakdowns; transparent on cost headwinds. Some hedging on timing (e.g., margin expansion "medium-to-long term" without specifics); Q&A handled mostly directly but evaded some competitive-intelligence questions. Strong: 16% core volume growth (4–5x market), EBITDA +37% YoY, pricing discipline maintained. However: sequential PAT decline (−5.2% QoQ) and margin below band suggest execution limits in inflation. Capex rollout on track but Silvassa spillover risk.

What to watch next
  • 1 · H2 FY27 (Oct–Mar)

    Recovery from monsoon; targeting 2x–3x market growth, AdBlue near double-digit 10–15%

  • 2 · Q4 FY27 (Jan–Mar)

    Chennai plant capacity increase go-live; Silvassa expansion spillover possible to Q1 FY28

  • 3 · FY28 H1

    Tirex 3,000 charger capacity online; new EV product portfolio, synthetic range scale-up to 10% of portfolio

Margin expansion to 14–16% remains aspirational; near-term execution on capacity ramp and cost absorption will determine credibility.

Informational and educational content only. Not investment advice.